These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23701520)

  • 1. Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004-10).
    Musah A; Gibson JE; Leonardi-Bee J; Cave MR; Ander EL; Bath-Hextall F
    Br J Dermatol; 2013 Nov; 169(5):1093-9. PubMed ID: 23701520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
    Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
    Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area.
    Bielsa I; Soria X; Esteve M; Ferrándiz C;
    Br J Dermatol; 2009 Dec; 161(6):1341-6. PubMed ID: 19796178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of worldwide incidence of nonmelanoma skin cancer.
    Lomas A; Leonardi-Bee J; Bath-Hextall F
    Br J Dermatol; 2012 May; 166(5):1069-80. PubMed ID: 22251204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
    Hammas K; Nardin C; Boyer S; Michel C; Aubin F; Woronoff AS
    Br J Dermatol; 2024 Sep; 191(4):519-528. PubMed ID: 38748494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of basal cell carcinoma in Lithuania, 1996-2010.
    Jurciukonyte R; Vincerzevskiene I; Krilaviciute A; Bylaite M; Smailyte G
    Br J Dermatol; 2013 Nov; 169(5):1100-5. PubMed ID: 23795568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995.
    Hannuksela-Svahn A; Pukkala E; Karvonen J
    Arch Dermatol; 1999 Jul; 135(7):781-6. PubMed ID: 10411152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma of the eyelid in Finland during 1953-97.
    Paavilainen V; Tuominen J; Pukkala E; Saari KM
    Acta Ophthalmol Scand; 2005 Apr; 83(2):215-20. PubMed ID: 15799736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
    Deady S; Sharp L; Comber H
    Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
    van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
    Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010.
    Rudolph C; Schnoor M; Eisemann N; Katalinic A
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):788-97. PubMed ID: 26213814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell carcinoma: histological classification and body-site distribution.
    Raasch BA; Buettner PG; Garbe C
    Br J Dermatol; 2006 Aug; 155(2):401-7. PubMed ID: 16882181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal study.
    Valery PC; Neale R; Williams G; Pandeya N; Siller G; Green A
    J Investig Dermatol Symp Proc; 2004 Mar; 9(2):148-51. PubMed ID: 15083782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study.
    Flohil SC; Seubring I; van Rossum MM; Coebergh JW; de Vries E; Nijsten T
    J Invest Dermatol; 2013 Apr; 133(4):913-8. PubMed ID: 23190883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
    Krynitz B; Olsson H; Lundh Rozell B; Lindelöf B; Edgren G; Smedby KE
    Br J Dermatol; 2016 Jan; 174(1):95-103. PubMed ID: 26333521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.